SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-011827
Filing Date
2018-11-01
Accepted
2018-11-01 09:30:25
Documents
5
Period of Report
2018-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 22746
2 LETTER FROM FOOD AND DRUG ADMINISTRATION gtbp_ex101.htm EX-10.1 3800
3 IMAGE gtbp_ex101000.jpg GRAPHIC 92047
4 IMAGE gtbp_ex101001.jpg GRAPHIC 28754
5 IMAGE gtbp_ex101002.jpg GRAPHIC 29316
  Complete submission text file 0001654954-18-011827.txt   235051
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 181152280
SIC: 2834 Pharmaceutical Preparations